Emergent BioSolutions to Release First Quarter 2022 Financial Results and Conduct Conference Call on April 28, 2022
April 08 2022 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, April 28, 2022, at 5:00 pm eastern time to discuss the
financial results for the first quarter of 2022, recent business
developments, revenue guidance for the second quarter of 2022, and
financial outlook for full year 2022.
This conference call can be accessed live by telephone or by
webcast:
Teleconference Information:Dial in number –
toll-free: (855) 766-6521Dial in number – toll:
(262) 912-6157Conference ID: 3691528
Webcast Information:Visit
https://edge.media-server.com/mmc/p/84272zeqfor the live
webcast.
A replay of the call can be accessed from the Investors page of
the Emergent website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For over 20 years, we’ve
been at work defending people from things we hope will never
happen—so we are prepared just in case they ever do. We provide
solutions for complex and urgent public health threats through a
portfolio of vaccines and therapeutics that we develop and
manufacture for governments and consumers. We also offer a range of
integrated contract development and manufacturing services for
pharmaceutical and biotechnology customers. To learn more about how
we plan to protect or enhance 1 billion lives by 2030, visit our
website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2023 to Aug 2024